Fulgent Genetics, Inc. is a leading healthcare company in the United States, specializing in genetic testing. With a low-risk ESG score of 18.3, Fulgent Genetics focuses on providing physicians with vital diagnostic information. The company's laboratory services business offers technical services and professional interpretation of results by licensed physicians. Additionally, Fulgent Genetics is dedicated to therapeutic development, with a focus on creating drug candidates for various cancers. The company operates primarily in the United States, with a small percentage of revenue generated from foreign markets.